Published in Scand J Rheumatol Suppl on January 01, 1975
Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med (1994) 4.76
Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med (1991) 4.09
ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis (1999) 3.69
World Health Organization and International League of Associations for Rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trials. J Rheumatol Suppl (1994) 2.23
HLA-B27, Klebsiella and ankylosing spondylitis: biological and chemical studies. Immunol Rev (1983) 1.99
Diaphragm function and lung involvement in systemic lupus erythematosus. Am J Med (1977) 1.83
Precipitating antibody to D.N.A. detected by two-stage electroimmunodiffusion. Study in S.L.E. and in rheumatoid arthritis. Lancet (1973) 1.69
Possible role of enteric organisms in the pathogenesis of ankylosing spondylitis and other seronegative arthropathies. Infect Immun (1983) 1.57
The mode of presentation of sarcoidosis in Finland and Hokkaido, Japan. A comparative analysis of 571 Finnish and 686 Japanese patients. Sarcoidosis Vasc Diffuse Lung Dis (1996) 1.47
Sarcoidosis in identical twins. Observations on the course of treated and untreated identical diseases. Am Rev Respir Dis (1973) 1.44
Lung cancer risk in hard-metal workers. Am J Epidemiol (1998) 1.31
Modulation of the infant immune responses by the first pertussis vaccine administrations. Vaccine (2006) 1.29
Elevated angiotensin I-converting enzyme in histiocytic medullary reticulosis. N Engl J Med (1983) 1.29
The frequency of sarcoidosis in Finland and Hokkaido, Japan. A comparative epidemiological study. Sarcoidosis (1995) 1.27
Immunochemical characterization of Klebsiella antigens which specifically modify an HLA-B27-associated cell-surface component. Hum Immunol (1982) 1.25
The value of tests for antibodies to DNA in monitoring the clinical course of SLE. A long-term study using the Farr test and the DNA counterimmunoelectrophoretic method. Clin Exp Immunol (1975) 1.24
Corticosteroid therapy of pulmonary sarcoidosis. A prospective evaluation of alternate day and daily dosage in stage II disease. Scand J Respir Dis (1979) 1.17
Angiotensin-converting enzyme and lysozyme in silicosis and asbestosis. Scand J Respir Dis (1978) 1.16
Assessment of activity in SLE: a clinical and serological study. Ann Rheum Dis (1975) 1.11
Safety of formoterol Turbuhaler at cumulative dose of 90 microg in patients with acute bronchial obstruction. Eur Respir J (2001) 1.06
Thrombocytosis in rheumatoid arthritis. Scand J Rheumatol (1972) 1.05
Thrombocytosis. Acta Med Scand (1973) 1.04
The immunopathology of ankylosing spondylitis--a review. Semin Arthritis Rheum (1985) 1.04
Skin test sensitivity and antigen-induced lymphocyte transformation in uraemia. Clin Exp Immunol (1973) 1.04
[Studies on hemolytic complement in certain osteoarticular diseases. Over-all results]. Presse Med (1966) 1.03
Pulmonary sarcoidosis in the Nordic countries 1950-1982. Epidemiology and clinical picture. Sarcoidosis (1990) 1.03
Safety of formoterol by Turbuhaler as reliever medication compared with terbutaline in moderate asthma. Eur Respir J (2002) 1.02
Formoterol (OXIS) Turbuhaler as a rescue therapy compared with salbutamol pMDI plus spacer in patients with acute severe asthma. Respir Med (2003) 1.02
[Development of a job-exposure matrix in the heavy-metal industry in France]. Rev Epidemiol Sante Publique (1997) 1.01
Persistence of HLA-B27 cross-reactive bacteria in bowel flora of patients with ankylosing spondylitis. Infect Immun (1984) 1.01
Cytotoxic T lymphocytes against disease-associated determinant(s) in ankylosing spondylitis. J Exp Med (1986) 0.99
Characterization of a factor(s) present in Klebsiella culture filtrates that specifically modifies an HLA-B27-associated cell-surface component. J Exp Med (1980) 0.99
Relationship between lung tissue and blood plasma concentrations of inhaled budesonide. Biopharm Drug Dispos (1993) 0.98
Advances in asthma and COPD treatment: combination therapy with inhaled corticosteroids and long-acting beta 2-agonists. Curr Pharm Des (2006) 0.98
Detection and characterization of DNA-anti-DNA complexes in a patient with systemic lupus erythematosus. Clin Exp Immunol (1977) 0.97
Immunofluorescent method for the detection of antigammaglobulin antibodies. Arthritis Rheum (1973) 0.96
Circulating immune complexes in sarcoidosis. J Clin Lab Immunol (1980) 0.96
True adherence with the Turbuhaler in young children with asthma. Arch Dis Child (2010) 0.95
The angiotensin-converting enzyme DD gene is associated with poor prognosis in Finnish sarcoidosis patients. Eur Respir J (1999) 0.94
Tolerability to high doses of formoterol and terbutaline via Turbuhaler for 3 days in stable asthmatic patients. Eur Respir J (1998) 0.94
Laparoscopic extraperitoneal adenomectomy (Millin): pilot study on feasibility. Eur Urol (2004) 0.93
Sarcoidosis and myeloma of lambda-type IgG. Acta Med Scand (1974) 0.92
Sarcoidosis with thyroid involvement, polymyalgia rheumatica and breast carcinoma. A case report. Scand J Rheumatol (1976) 0.92
Serum lysozyme in sarcoidosis. Evaluation of its usefulness in determination of disease activity. Scand J Respir Dis (1977) 0.92
Significance of non-pathogenic cross reactive bowel flora in patients with ankylosing spondylitis. Ann Rheum Dis (1986) 0.91
Prognostic significance of lymphopenia in sarcoidosis. Acta Med Scand (1979) 0.91
Aortitis with dissection complicating systemic lupus erythematosus. Pathology (1995) 0.91
The prognosis of pulmonary sarcoidosis in Finland and Hokkaido, Japan. A comparative five-year study of biopsy-proven cases. Sarcoidosis Vasc Diffuse Lung Dis (2000) 0.90
Treatment with inhaled steroids in patients with symptoms suggestive of asthma but with normal lung function. Eur Respir J (2008) 0.89
Kveim reaction in Crohn's disease. Lancet (1971) 0.88
The enigma of the Klebsiella connection and ankylosing spondylitis: a commentary. Hum Immunol (1984) 0.88
A review of currently available vessel sealing systems. Minim Invasive Ther Allied Technol (2007) 0.88
Family studies in dermatitis herpetiformis. Ann Clin Res (1976) 0.88
HLA-B27 associated cross-reactive marker on the cells of New Zealand patients with ankylosing spondylitis. Ann Rheum Dis (1986) 0.87
Phosphine sampling and analysis using silver nitrate impregnated filters. J Environ Monit (2000) 0.87
Thrombocythaemia and multiple myeloma. A report on two cases. Acta Med Scand (1977) 0.86
Cross-reactivity between environmental agents and HLA-B2. Lancet (1980) 0.86
Lupus-like syndrome associated with pulmonary reaction to nitrofurantoin. Report of three cases. Acta Med Scand (1975) 0.86
Galectin-1 and galectin-3 binding pattern expression in renal cell carcinomas. Am J Clin Pathol (1999) 0.86
Pulmonary reaction to nitrofurantoin. Acta Med Scand (1969) 0.85
The distribution of a specific HLA-B27-associated cell surface component on the tissues of patients with ankylosing spondylitis. Clin Exp Immunol (1981) 0.85
Pulmonary sarcoidosis in the Nordic countries 1950-1982. II. Course and prognosis. Sarcoidosis (1990) 0.85
Antirheumatic drugs: a proposed new classification. Arthritis Rheum (1993) 0.85
A double-blind, placebo-controlled dose-response study with budesonide Turbuhaler in Japanese asthma patients. Japanese Pulmicort Turbuhaler study group. Respirology (2000) 0.85
Familial sarcoidosis in Finland and Hokkaido, Japan--a comparative study. Respir Med (1999) 0.85
Immunoglobulins in pernicious anaemia. Including a report on a patient with pernicious anaemia, IgA deficiency and an M component of kappa-type IgG. Acta Med Scand (1973) 0.85
Classification strategies for the grading of renal cell carcinomas, based on nuclear morphometry and densitometry. J Pathol (1997) 0.85
Thrombocytes in fibrinogen-induced arthritis in rabbits. Scand J Rheumatol (1973) 0.84
Dose response studies and longterm evaluation of auranofin in rheumatoid arthritis. J Rheumatol (1988) 0.84
Effects of inhaled corticosteroids on metalloproteinase-8 and tissue inhibitor of metalloproteinase-1 in the airways of asthmatic children. Int Arch Allergy Immunol (2009) 0.84
Formoterol Turbuhaler as reliever medication in patients with acute asthma. Eur Respir J (2006) 0.84
Clinical relevance is associated with allergen-specific wheal size in skin prick testing. Clin Exp Allergy (2014) 0.83
Formoterol as needed with or without budesonide in patients with intermittent asthma and raised NO levels in exhaled air: A SOMA study. Eur Respir J (2006) 0.83
[Risk of lung disease in dental technicians]. Rev Fr Prothese Dent (1980) 0.83
Sarcoidosis of the spleen. Acta Med Scand (1976) 0.83
Beta 2-agonists administered by a dry powder inhaler can be used in acute asthma. Respir Med (1998) 0.83
Pseudo-clinical Fabry's disease without alpha galactosidase deficiency. Biomedicine (1977) 0.82
[Immunological disorders in rheumatoid polyarthritis: their place in the pathogenesis of synovial inflammation]. Bull Mem Soc Med Hop Paris (1967) 0.82
Angiotensin converting enzyme. III. Changes in serum level as an indicator of disease activity in untreated sarcoidosis. Scand J Respir Dis (1979) 0.82
HLA-B27, molecular mimicry, and ankylosing spondylitis: popular misconceptions. Ann Rheum Dis (1987) 0.82
[A new, organ-specific antibody in the course of chronic hepatitis]. Med Chir Dig (1974) 0.82
Fine-needle aspiration biopsy of the spleen in diagnosis of sarcoidosis. Ann N Y Acad Sci (1976) 0.81
Evaluation of anti-nuclear antibody tests. A Report on The Workshop of the Australian Rheumatism Association, October 1980. Pathology (1981) 0.81
Exudative pleurisy and sarcoidosis. Br J Dis Chest (1966) 0.81
Activity of serum adenosine deaminase in sarcoidosis. Clin Chem (1985) 0.81
Immunolocalization of a 43 kDa peroxisomal membrane protein in the liver of patients with generalized peroxisomal disorders. Eur J Cell Biol (1995) 0.81
[Action of homologous thyroid extract on guinea pig lymph node cells in culture during and apart from experimental auto-allergic thyroiditis]. Ann Inst Pasteur (Paris) (1970) 0.80
How many life years are lost in patients with rheumatoid arthritis? Secular cause-specific and all-cause mortality in rheumatoid arthritis, and their predictors in a long-term Australian cohort study. Intern Med J (2013) 0.79
Comparing asthma treatment in elderly versus younger patients. Respir Med (2011) 0.79
Rabbit antisera to cross-reactive organisms--where's the problem. Ann Rheum Dis (1986) 0.79
Usefulness of fine-needle aspiration biopsy of spleen in diagnosis of sarcoidosis. Chest (1983) 0.79
Pubic osteolysis. J Bone Joint Surg Am (1984) 0.79
Asthma and COPD: differences and similarities. With special reference to the usefulness of budesonide/formoterol in a single inhaler (Symbicort) in both diseases. Int J Clin Pract (2005) 0.79
Angiotensin-converting enzyme. II. Serum activity in early and newly diagnosed sarcoidosis. Scand J Respir Dis (1979) 0.78
Isohormones: molecular forms of the human chorionic somatomammotropic hormone. Eur J Biochem (1975) 0.78
Dosimetry of transmission measurements in nuclear medicine: a study using anthropomorphic phantoms and thermoluminescent dosimeters. Eur J Nucl Med (1998) 0.78
Letter: Precipitating antibodies in systemic lupus. Lancet (1974) 0.78
Proceedings: Circulating complexes and disease activity in SLE. Ann Rheum Dis (1975) 0.78
Construct validity of the chicken model in the simulation of laparoscopic radical prostatectomy suture. J Endourol (2006) 0.78